Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States — The NIH RADx Initiative

In April 2020, Congress appropriated $1.5 billion to the NIH to increase national testing capacity for SARS-CoV-2. The NIH established the Rapid Acceleration of Diagnostics program to support the development and deployment of accurate, rapid tests. Among the goals of RADx is to increase capacity to...

Full description

Saved in:
Bibliographic Details
Published inNew England Journal of Medicine Vol. 383; no. 11; pp. 1071 - 1077
Main Authors Tromberg, Bruce J, Schwetz, Tara A, Pérez-Stable, Eliseo J, Hodes, Richard J, Woychik, Richard P, Bright, Rick A, Fleurence, Rachael L, Collins, Francis S
Format Journal Article Web Resource
LanguageEnglish
Published United States Massachusetts Medical Society 10.09.2020
Subjects
Clinical Laboratory Techniques - statistics & numerical data
Clinical Laboratory Techniques - trends
Coronavirus Infections - diagnosis
Coronaviruses
COVID-19
COVID-19 diagnostic tests
COVID-19 Testing
Diagnostic tests
Humans
Innovations
Laboratories
Medical diagnosis
Pandemics
Pneumonia, Viral - diagnosis
Point-of-Care Testing - trends
Reverse Transcriptase Polymerase Chain Reaction
Serologic Tests
Severe acute respiratory syndrome coronavirus 2
Special Report
United States
United States
United States > US
Online AccessGet full text

Cover

More Information
Summary:In April 2020, Congress appropriated $1.5 billion to the NIH to increase national testing capacity for SARS-CoV-2. The NIH established the Rapid Acceleration of Diagnostics program to support the development and deployment of accurate, rapid tests. Among the goals of RADx is to increase capacity to enable testing of approximately 2% of the U.S. population (6 million persons) per day by December 2020.
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMsr2022263